World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ANZCTR
Last refreshed on: 13 January 2020
Main ID:  ACTRN12613001162707
Date of registration: 21/10/2013
Prospective Registration: Yes
Primary sponsor: Dr Helen Lunt
Public title: Effect of prandial status on capillary - venous glucose gradient in type 1 diabetes
Scientific title: Effect of prandial status on [capillary-venous] glucose difference, in participants with well controlled type 1 diabetes
Date of first enrolment: 18/11/2013
Target sample size: 40
Recruitment status: Completed
URL:  https://anzctr.org.au/ACTRN12613001162707.aspx
Study type:  Observational
Study design:  Purpose: Natural history;Duration: Cross-sectional;Selection: Defined population;Timing: Prospective;  
Phase:  Not Applicable
Countries of recruitment
New Zealand
Contacts
Name: Dr Helen Lunt   
Address:  Diabetes Centre 550 Hagley Ave Riccarton Christchurch 8001 New Zealand
Telephone: +64 3 3640860
Email: helen.lunt@cdhb.health.nz
Affiliation: 
Name: Dr Helen Lunt   
Address:  Diabetes Centre 550 Hagley Ave Riccarton Christchurch 8001 New Zealand
Telephone: +64 3 3640860
Email: helen.lunt@cdhb.health.nz
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: Type 1 diabetes, HbA1c <65mol/mol, on CSII or MDI insulin, ability to estimate insulin:carbohydrate ratio
Exclusion criteria: Pregnancy

Age minimum: 18 Years
Age maximum: No limit
Gender: Both males and females
Health Condition(s) or Problem(s) studied
Metabolic and Endocrine - Diabetes
Type 1 diabetes;
Type 1 diabetes
Intervention(s)
Capillary and venous glucose responses will be measured one hour and two hours after a buffet breakfast, the content of which is selected by participants. Total period of observation is two hours.
Primary Outcome(s)
[Capillary -venous] glucose gradient, at the two hour post prandial time point. Duplicate capillary and venous glucose measurements will be assessed using two meter/strip systems with differing enzyme systems, namely the Nova StatStrip and the Accu-chek Performa. Venous plasma glucose will also undergo rapid plasma separation using a PST tube, followed by laboratory measurement using the hexakinase method and this venous value will be used as an ancillary measure of [capillary-venous] difference.
[Two hours]
Secondary Outcome(s)
[Capillary -venous] glucose gradient, at the one hour post prandial time point. Assessment of glucose is otherwise identical to that of the primary outcome (StatStrip and Performa glucose meters used to measure both capillary and venous samples,with a further check of venous glucose, undertaken by measuring plasma glucose in the laboratory). [One hour]
Secondary ID(s)
none
Source(s) of Monetary Support
Diabetes Christchurch
Secondary Sponsor(s)
University of Otago Christchurch
Ethics review
Status: Approved
Approval date:
Contact:
Health and Disability Ethics Committee
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history